Patent · US Active

Spiroindolinone derivatives

US7638548B2 · kind B2 · utility

14Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2007
Grant dateDec 29, 2009
Priority date
Expiry dateJun 16, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There are provided compounds of the general formulaswherein X, Y, R1, R2, R3 and R4 are as described herein. The compounds exhibit anticancer activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.